Chetan T. Goudar is an Executive Director of Process Development at Amgen. His team is responsible for developing Drug Substance processes for all molecules in Amgen’s polymodal late-stage pipeline and enabling progression of these assets to commercial licensure. His team is also engaged in advancing drug substance manufacturing through the application of continuous principles across both synthetic and biologic modalities. Prior to joining Amgen in 2012, Chetan spent 13 years at Bayer HealthCare’s Process Development group in Berkeley. He is a recipient of the ACS BIOT and the Biochemical...Read more
Dr. Ok is a full professor at and global research director of Korea University in Seoul, Korea. His academic background covers waste management, the bioavailability of emerging contaminants, and bioenergy and value-added products (such as biochar). Professor Ok also has experience in fundamental soil science and the remediation of various contaminants in soils and sediments. Together with graduate students and colleagues, Professor Ok has published over 600 research papers, 60 of...Read more
Dr. Jay Amarasekera is an independent consultant supporting startups and investors in identifying and commercializing breakthrough technologies. Most recently he was a Senior Technology Manager attached SABIC Ventures, the corporate venture arm of Saudi Basic Industries Corporation. Prior to this role, Jay served as a Technology Manager for Performance Chemicals and Innovative Plastics business units. Before SABIC, he served in many managerial positions in General Electric’s former Plastics and Silicones businesses both in USA and China. Prior to joining GE, Jay worked as a Research...Read more
FOR REASONS BEYOND OUR CONTROL, THE MARCH MEETING IS BEING CANCELLED AND MAY BE RESCHEDULED AT A LATER DATE Speakers: John Waldrop has over 35 years of experience in aerospace materials and processing technology. Cole Maxfield has experience as a full time software engineer and has built an...Read more
